/

Sociétés

Ju

Non vérifié

Juniper Biosciences

Ce que nous écrivons

Annonces ÉconomiquesBiotechnologieFinanceMédecine Santé Bien-être

5 communiqués de presse

Voir tous les communiqués de presse

15/09/2026

Biotechnologie

Annonces Économiques

Juniper Biosciences Unveils JBS-002 and JBS-004, Advancing Two Late-Stage Diagnostic Programs to Registration Batch Manufacturing in the Fourth Quarter of 2026

Source

Juniper Biosciences

Émetteur

1.00

0

01/09/2026

Biotechnologie

Médecine Santé Bien-être

Juniper’s JBS-003 (F-MISO) Program Receives FDA Breakthrough Therapy Designation, Advancing a First-in-Class Hypoxia Tracer Enabling Radiation De-escalation in HPV-Positive Head and Neck Cancer

Source

Juniper Biosciences

Émetteur

1.00

0

18/05/2026

Biotechnologie

Juniper Biosciences Appoints Renowned Radiopharmaceutical Expert Jason S. Lewis, Ph.D. as Chair of Newly Formed Scientific Advisory Board

Source

Juniper Biosciences

Émetteur

1.00

0

28/04/2026

Biotechnologie

Juniper Biosciences Announces Strategic Collaboration with leading global cancer center on F-MISO (JBS-003): A First-in-Class Precision Diagnostic Poised to Revolutionize Head and Neck Cancer Treatment

Source

Juniper Biosciences

Émetteur

1.00

0

01/12/2025

Biotechnologie

Finance

Médecine Santé Bien-être

Juniper Biosciences Raises Oversubscribed and Upsized $40 Million Seed Financing to Fund Development of Its Innovative Pipeline

Source

Juniper Biosciences

Émetteur

1.00

0

Followers

0

Compatibilité

0